Cava C et al., in their study (2020) using ten samples of HER2+ BC human tissue and corresponding non-cancerous samples, showed that hsa-mir-429 was upregulated in tumor samples, supporting a diagnostic role, especially for HER2-positive BC patients [60]. This evidence concerns the gene ERBB2 and breast cancer.